amiloride has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeGrado, WF; Hong, M; Jo, H; Medeiros-Silva, J; Somberg, NH; Wang, J | 1 |
| Glebov, OO | 1 |
| Adil, MS; Narayanan, SP; Somanath, PR | 1 |
| Carlin, AF; Castro, DV; Clark, AE; Croker, BA; De Angelis, AA; Guatelli, J; Lewinski, MK; Oom, AL; Opella, SJ; Park, SH; Siddiqi, H; Stoneham, CA | 1 |
| Hudák, A; Letoha, A; Letoha, T; Szilák, L | 1 |
1 review(s) available for amiloride and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
Topics: Alveolar Epithelial Cells; Amiloride; Antiviral Agents; Caveolae; Chlorpromazine; Clathrin-Coated Vesicles; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Humans; Itraconazole; Lung; Lysosomes; Nystatin; Pinocytosis; SARS-CoV-2; Vinblastine; Virus Internalization | 2020 |
4 other study(ies) available for amiloride and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Hexamethylene amiloride binds the SARS-CoV-2 envelope protein at the protein-lipid interface.
Topics: Amiloride; COVID-19; Humans; Lipid Bilayers; SARS-CoV-2 | 2023 |
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?
Topics: A549 Cells; Amiloride; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Down-Regulation; Epithelial Sodium Channel Blockers; Host-Pathogen Interactions; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Virus Internalization | 2020 |
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.
Topics: Amiloride; Animals; Antiviral Agents; Binding Sites; Chlorocebus aethiops; Coronavirus Envelope Proteins; COVID-19; COVID-19 Drug Treatment; Humans; Ion Channels; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Conformation; Protein Domains; SARS-CoV-2; Vero Cells; Virus Assembly | 2021 |
Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
Topics: Amiloride; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Cell Survival; COVID-19; Epithelial Sodium Channel Blockers; Humans; Peptides; Protein Domains; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Syndecan-4; Syndecans; Virus Internalization | 2021 |